Stephen H. Sands - 22 Feb 2022 Form 3 Insider Report for Cyteir Therapeutics, Inc.

Role: Director
Signature: /s/ Andrew Gengos, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 22 Feb 2022
Net transactions value: $0
Form type: 3
Filing time: 24 Feb 2022, 15:49:43 UTC
Next filing: 07 Feb 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney